Company Filing History:
2 out of 870 
2 out of 5,094 
Years Active: 2009-2014
Title: Marie Pascale Frenkiel: Innovator in Viral Vector Development
Introduction
Marie Pascale Frenkiel is a prominent inventor based in Levallois, France. She has made significant contributions to the field of virology, particularly in the development of vaccines and therapeutic applications for viral infections. With a total of 2 patents, her work focuses on the Dengue and West Nile viruses.
Latest Patents
Frenkiel's latest patents include innovations related to the proteins and genes of Dengue and West Nile viruses. These inventions involve the development of viral vectors that express various immunogens from the West Nile Encephalitis Virus (WNV) and the Dengue virus. The goal of her research is to induce protective humoral and cellular immune responses against these viral infections. Specifically, her patents detail three antigens from WNV, including the secreted envelope glycoprotein (E), the heterodimer glycoproteins (pre-M-E), and the NSI protein. Additionally, she addresses antigens from the Dengue virus, such as the secreted envelope glycoprotein (e), the heterodimer glycoproteins (pre-m-e), and the nsl protein, emphasizing their use in vaccinal, therapeutic, and diagnostic applications.
Career Highlights
Throughout her career, Marie Pascale Frenkiel has worked with esteemed institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. Her research has significantly advanced the understanding of viral infections and the development of effective vaccines.
Collaborations
Frenkiel has collaborated with notable colleagues, including Frédéric Tangy and Philippe Despres, contributing to the collective knowledge and innovation in her field.
Conclusion
Marie Pascale Frenkiel's work in the development of viral vectors for Dengue and West Nile viruses showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against viral infections, and her patents reflect her innovative spirit and commitment to public health.